Diabetes Drug Made For Under $5 Costs Americans $1,000, Drawing Comparisons To Martin Shrikeli While Juicing Profits for A Drug Giant

The stock of Danish drugmaker Novo Nordisk NVO has been on a tear, up over 400% in the past five years. It's been so successful that its nearly $500 billion market cap exceeds Denmark’s entire gross domestic product (GDP), where the company is based. Novo Nordisk owes much of its success to its…#danish #novonordisknvo #denmark #novonordisk #uberfacebookand #apple #melissabarber #yaleuniversity #yale #reddit
Source: Reuters: Health - Category: Consumer Health News Source Type: news